 |
 |
 |
|
 |
articles < press << main |
 |
 |
|
|
|
|
|
|
|
| date | | | | title / topic / summary | sort by topic |
|---|
|
| 01/22/2004 | | | | Nymox Rated “Buy” in New Analyst Report From TNI Securities
topic: Financial
January 22, 2004: Nymox Pharmaceutical Corporation has been given a “Buy” recommendation in new analyst coverage by Eric Yee of TNI Securities. |
| 12/31/2003 | | | | New Study Shows Importance of Nymox AlzheimAlert™ Protein to Alzheimer's Disease
topic: AlzheimAlert™ & Diagnosis of Alzheimer's Disease
December 31, 2003: Nymox Pharmaceutical Corporation announced today that significant new evidence linking the brain protein detected by the Company's AlzheimAlert™ test to the Alzheimer's disease process has been published in the latest issue of Cellular and Molecular Life Sciences (Cell Mol Life Sci Dec 2003; 60(12): 2679-91). The study by a research team at Brown Medical School led by Dr. Suzanne de la Monte found that the AlzheimAlert™ brain protein (NTP or neural thread protein) is physically associated with important structural brain cell proteins known to accumulate abnormally in Alzheimer's disease. |
| 12/22/2003 | | | | Five Independent Analyst Reports Recommend Nymox
topic: Financial
December 22, 2003: Five independent analyst reports currently recommend Nymox Pharmaceutical Corporation. |
| 12/18/2003 | | | | New Study Confirms Nymox NXC-4720 Product Effective Against E. Coli
topic: R&D: E coli and Other Antibacterial Treatments
December 18, 2003: Nymox Pharmaceutical Corporation announced today the results of a new study that showed that treatment of meat with the Company's NXC-4720 product substantially reduced deadly E. coli contamination. |
| 12/16/2003 | | | | Nymox Pharmaceutical Rated “Bullish” by Standard & Poor's Stock Reports
topic: Financial
December 16, 2003: Nymox Pharmaceutical Corporation receives favorable coverage in a new Standard & Poor's Stock Report. The new report on Nymox rates the stock as “bullish” on technical evaluation. |
| 12/09/2003 | | | | Four Independent Analyst Reports Recommend Nymox
topic: Financial
December 9, 2003: Four independent analyst reports currently recommend Nymox Pharmaceutical Corporation. |
| 11/26/2003 | | | | Nymox Rated “Buy” in Initial Coverage Report by CGF Securities
topic: Financial
November 26, 2003: Nymox Pharmaceutical Corporation has been given a “Buy” recommendation in an Initial Report from CGF Securities. |
| 11/18/2003 | | | | Nymox Shares Rated a Buy in Analyst Report
topic: Financial
November 18, 2003: Nymox Pharmaceutical Corporation announced today that a new research note from J.M. Dutton & Associates gives the Company a “Buy” rating. |
| 11/14/2003 | | | | Nymox Reports Third Quarter Results
topic: Financial
November 14, 2003: Nymox Pharmaceutical Corporation announced today its financial results for the third quarter of 2003. |
| 11/11/2003 | | | | Nymox Will File Premarket Approval Application – PMA – with FDA for Alzheimer Urine Test
topic: AlzheimAlert™ & Diagnosis of Alzheimer's Disease
November 11, 2003: Nymox Pharmaceutical Corporation announced today that it will file a Premarket Approval application (PMA) with the FDA for the Company's Alzheimer urine test (AlzheimAlert™) before the end of this year. |
|